Advertisement

Topics

Eisai forecasts growth in revenue, profit for fiscal year 2019 as Lenvima sales more than double in Q4 https://www.firstwordpharma.com/node/1640469 

06:42 EDT 13 May 2019 | FirstWord Pharma

Eisai forecasts growth in revenue, profit for fiscal year 2019 as Lenvima sales more than double in Q4 https://www.firstwordpharma.com/node/1640469 

Original Article: Eisai forecasts growth in revenue, profit for fiscal year 2019 as Lenvima sales more than double in Q4 https://www.firstwordpharma.com/node/1640469 

NEXT ARTICLE

More From BioPortfolio on "Eisai forecasts growth in revenue, profit for fiscal year 2019 as Lenvima sales more than double in Q4 https://www.firstwordpharma.com/node/1640469 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...